跳至主要内容
临床试验/CTRI/2025/05/086236
CTRI/2025/05/086236尚未招募2/3 期

study to evaluate the efficacy of eladyo modak in the management of Madatyaya (Alcohol use disorder)

PT KHUSHILAL SHARMA GOVERNMENT AUTONOMOUS AYURVEDA COLLEGE AND INSTITUTE BHOPAL MP1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年5月19日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
efficacy of Eladyo modak in the management of Madatyaya (AUD).

研究概览

简要总结

The harmful use of alcohol is a component cause of more than 200 disease and injury conditions in individuals, most notably alcohol dependence, liver cirrhosis, cancers and injuries. Drinking alcohol is associated with a risk of developing health problems such as mental and behavioral disorders, including alcohol dependence, and major non communicable diseases such as liver cirrhosis, some cancers and cardiovascular diseases.[1]

By understanding the risk factors, patterns of alcohol use, and the impact of alcohol on health, a study is made to establish the effectiveness of Eladyo modak in the management of Madatyaya (AUD).

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient of the age group 20-60 years.
  • Patient present with the symptoms of Madatyaya and AUDIT score equal to 8 or above .
  • Patient of either sex will be selected irrespective of caste, creed, religion, occupation, habitat etc.
  • Patient provides informed consent prior to initiation of study procedure and is willing to join the study.

排除标准

  • Alcohol addicted patients suffering from Liver Cirrhosis, liver cancer, Gastrointestinal bleeding, developed ascites.
  • Alcohol addicted patients who were suffering from major psychiatric disorders or mentally unfit to follow advised treatment.
  • Alcohol addicted patients suffering from major systemic illness like cancer, diabetes, hypertension, myocardial infarction, ischemic heart disease, pulmonary tuberculosis etc.

结局指标

主要结局

efficacy of Eladyo modak in the management of Madatyaya (AUD).

时间窗: 3 weeks

次要结局

  • It is further expected that this study will be able to provide information related to the safety of the drug in the management of madatyaya & the relief in symptoms of madatyaya.(11 months)

研究者

发起方
PT KHUSHILAL SHARMA GOVERNMENT AUTONOMOUS AYURVEDA COLLEGE AND INSTITUTE BHOPAL MP
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Roshni Tiwari

Pt. Khushilal sharma govt ayurveda college, Bhopal

研究点 (1)

Loading locations...

相似试验